Literature DB >> 2660309

The acute onset of nausea and vomiting following stereotactic radiosurgery: correlation with total dose to area postrema.

E Alexander1, R L Siddon, J S Loeffler.   

Abstract

From 1986 to 1988, 44 patients have been treated for tumors or vascular lesions with stereotactic radiosurgery using a modified standard linear accelerator. In seven patients, nausea and vomiting occurred within 6 hours after the completion of radiosurgery. One of these patients with nausea and occasional vomiting pretreatment had exacerbation several hours after treatment, in spite of droperidol and prochlorperazine prophylaxis. Nausea and vomiting in the other six patients was self-limited and was completely resolved by 12 hours from onset. None of these six patients suffered from nausea and vomiting before treatment. This was directly correlated with the total dose to the vomiting center in the floor of the fourth ventricle (area postrema). The median dose to the vomiting center in the seven patients was 618 cGy (range 275-1257). The final patient in the series received 1088 cGy to the area postrema after droperidol and dexamethasone prophylaxis without developing nausea or vomiting. In the remaining 36 patients who received from less than 5 to 184 cGy to area postrema, nausea and vomiting did not occur. We recommend that patients treated with large fractions of radiation by radiosurgery in this area be premedicated appropriately.

Entities:  

Mesh:

Year:  1989        PMID: 2660309     DOI: 10.1016/0090-3019(89)90033-5

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  3 in total

1.  Glioblastoma revisited: do clinical observations match basic science theory? Radiosurgery: clinical observations.

Authors:  E Alexander
Journal:  J Neurooncol       Date:  1993-08       Impact factor: 4.130

2.  Beam path toxicity in candidate organs-at-risk: assessment of radiation emetogenesis for patients receiving head and neck intensity modulated radiotherapy.

Authors:  Esengul Kocak-Uzel; G Brandon Gunn; Rivka R Colen; Micheal E Kantor; Abdallah S R Mohamed; Sara Schoultz-Henley; Paniyotis Mavroidis; Steven J Frank; Adam S Garden; Beth M Beadle; William H Morrison; Jack Phan; David I Rosenthal; Clifton D Fuller
Journal:  Radiother Oncol       Date:  2014-04-17       Impact factor: 6.280

Review 3.  Dose tolerance limits and dose volume histogram evaluation for stereotactic body radiotherapy.

Authors:  Jimm Grimm; Tamara LaCouture; Raymond Croce; Inhwan Yeo; Yunping Zhu; Jinyu Xue
Journal:  J Appl Clin Med Phys       Date:  2011-02-08       Impact factor: 2.243

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.